Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    April 2018
  1. TUMINELLO S, Liu B, Wolf A, Alpert N, et al
    Comparison of In-Hospital and Long-term Outcomes of Sublobar Lung Cancer Surgery by VATS and Open Techniques.
    Am J Clin Oncol. 2018 Apr 10. doi: 10.1097/COC.0000000000000440.
    PubMed     Text format     Abstract available


    March 2018
  2. NIHO S, Ikeda N, Michimae H, Suzuki K, et al
    Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non-Small Cell Lung Cancer: Thoracic Oncology Resear
    Am J Clin Oncol. 2018 Mar 7. doi: 10.1097/COC.0000000000000438.
    PubMed     Text format     Abstract available


  3. LAFUENTE-SANCHIS A, Estors-Guerrero M, Zuniga A, Martinez-Hernandez NJ, et al
    Clinical Significance of Molecular Micrometastasis in the Sentinel Lymph Node of Early-stage Non-Small Cell Lung Cancer Patients.
    Am J Clin Oncol. 2018 Mar 5. doi: 10.1097/COC.0000000000000432.
    PubMed     Text format     Abstract available


    January 2018
  4. FIORICA F, Belluomini L, Stefanelli A, Santini A, et al
    Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination.
    Am J Clin Oncol. 2018 Jan 31. doi: 10.1097/COC.0000000000000428.
    PubMed     Text format     Abstract available


    November 2017
  5. JEREMIC B
    Induction Therapies Plus Surgery Versus Exclusive Radiochemotherapy in Stage IIIA/N2 Non-Small Cell Lung Cancer (NSCLC).
    Am J Clin Oncol. 2017 Nov 7. doi: 10.1097/COC.0000000000000416.
    PubMed     Text format     Abstract available


    October 2017
  6. YOSHIMURA N, Tada T, Matsumoto Y, Sawa K, et al
    Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non-small Cell Lung Cancer: The Fin
    Am J Clin Oncol. 2017 Oct 17. doi: 10.1097/COC.0000000000000412.
    PubMed     Text format     Abstract available


    March 2017
  7. BECKER DJ, Levy BP, Gold HT, Sherman SE, et al
    Influence of Extent of Lymph Node Evaluation on Survival for Pathologically Lymph Node Negative Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2017 Mar 15. doi: 10.1097/COC.0000000000000379.
    PubMed     Text format     Abstract available


    June 2016
  8. DEEK MP, Kim S, Ahmed I, Fang BS, et al
    Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  9. RAGHUNATHAN R, Cease K, Troeschel S, Zhao L, et al
    Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  10. MAQUILAN G, Grover S, Xanthopoulos E, Evans TL, et al
    Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  11. SMALL W JR, James JL, Moore TD, Fintel DJ, et al
    Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  12. CHOI YW, Jeon SY, Jeong GS, Lee HW, et al
    EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  13. BUCHBINDER EI, Desai A
    CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition.
    Am J Clin Oncol. 2016;39:98-106.
    PubMed     Text format     Abstract available


    January 2016
  14. HAQUE W, Szeja S, Tann A, Kalra S, et al
    Changes in Treatment Patterns and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in the United States After the Incorporation of Stereotactic Ablative Radiation Therapy: A Population-based Analysis.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  15. LANNI TB JR, Stevens C, Farah M, Boyer A, et al
    Early Results From the Implementation of a Lung Cancer Screening Program: The Beaumont Health System Experience.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: